Merck/Schering Zetia (Ezetimibe) Will Be Supported By Three Sales Forces

Merck will follow the Zocor model in launching Zetia (ezetimibe) into the cholesterol-lowering class by relying on separate sales forces and a co-promotion partner to establish the new product